new trials of targeting therapies to treat leptomeningeal carcinomatosis
Published 7 years ago • 969 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
29:12
gracecast-072_lung-cancer_q&a on prevention and treatment of brain metastases
-
2:43
nrg1 fusions: treatment options - targeted therapies in lung cancer 2023
-
3:37
2020 ttf egfr qa panel increase in leptomeningeal disease & connection with mutation pos. nsclc
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
2:21
ret fusion treatment: pralsetinib - targeted therapies in lung cancer 2023
-
2:11
video iaslc riess treating lmc
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
2:56
grace targeted therapies lung cancer 2021 - what trials are available for ntrk resistant mutation?
-
5:42
osimertinib and the flaura trial
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
11:36
immunotherapy for lung cancer: currently enrolling clinical trials of combination therapies
-
1:09:58
breakout second stage 2023 targeted therapies in lung cancer forum on-demand
-
5:32
melanoma updates leptomeningeal disease/ brain mets in melanoma
-
3:49
ret fusion treatment: selpercatinib - targeted therapies in lung cancer 2023
-
11:12
the future of cancer immunotherapy: combination treatments
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
5:30:11
full event mainstage 2023 targeted therapies in lung cancer patient forum on-demand